Vitamin D Deficiency Increases Severity of Paclitaxel-Induced Peripheral Neuropathy

PURPOSE: Approximately 25% of patients receiving weekly paclitaxel for breast cancer require treatment disruptions to avoid severe, irreversible peripheral neuropathy (PN). Vitamin insufficiencies are PN risk factors in many diseases, but their relevance to chemotherapy-induced PN is unknown. METHOD...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Breast Cancer Res Treat
Auteurs principaux: Jennaro, Theodore, Fang, Fang, Kidwell, Kelley M, Lavoie Smith, Ellen M., Vangipuram, Kiran, Burness, Monika L, Griggs, Jennifer J., Van Poznak, Catherine, Hayes, Daniel F., Henry, N. Lynn, Hertz, Daniel L.
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7945004/
https://ncbi.nlm.nih.gov/pubmed/32166478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05584-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires